Cotinga Pharmaceuticals Inc - Ordinary Shares

(COTQF)

By |
Cotinga Pharmaceuticals Inc - Ordinary Shares

Profile

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical research, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene and the second clinical research, COTI-219, is a novel oral small molecule compound targeting the mutant forms. The company uses various technologies that are Chemas: which is a multi-staged computational platform technology based upon a hybrid of machine learning technologies and proprietary algorithms, Rosalind; which is a smart data platform designed to provide better personalized treatment options to cancer patients, and Chemfirm; which is positioned to rapidly and meaningfully improve the drug discovery process and improve biopharmaceutical investment performance.

Contact Information

Website: cotingapharma.com
Email: gkelly@criticaloutcome.com
Main Phone: +1 519 858-5157
Address: 100 Collip Circle
Address 2: Suite 230B, The Mogenson Centre
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: OTCQB
CEO: Alison Silva
Employees: 6
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0362 $ 0. (0.00%)
Last Price 0.0362 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0362
Last Trade Volume 0 52 Wk Hi 1.40 52 Wk Low 0.01
Market Cap 604,068 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 16,686,968.00 EPS (TTM) -0.25 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.65 3.65 3.65 3.65
Low Target Price Estimate 3.65 3.65 3.65 3.65
Mean Target Price Estimate 3.65 3.65 3.65 3.65
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/01/18 02/01/18 02/01/18 02/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago